Thrombotic thrombocytopenic purpura

Report of fourteen cases—occurrence during pregnancy and response to plasma exchange

Vincent Caggiano, Leonor P Fernando, Jack M. Schneider, Hanns C. Haesslein, Edward J. Watson‐Williams

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Thrombotic thrombocytopenic purpura (TTP), a syndrome of diverse etiology probably related to factors regulating platelet‐vessel wall interaction, is predominantly a disorder of women. We report our experience with 14 patients in an 11‐year period. Thirteen were female and aged between 25–69 years. Four were postmenopausal, and of the nine premenopausal women three were pregnant, one was immediately postpartum, and three were taking estrogennine premenopausal women three were pregnant, one was immediately postpartum, and three were taking estrogen‐containing oral contraceptives. A review of the literature confirms the two to one female/male preponderance and that TTP is reported in 56 women who are pregnant or recently postpartum. While this association with possible hormonal events has been noted, it has previously received little comment. We stress the similarity between TTP and some occurrences of preeclamptic toxemia, and that this may suggest not only a common etiology but that therapeutic attempts should be similar. While no single therapeutic modality is universally successful, our experience is that plasma exchange is the most effective, with five of seven patients so‐treated obtaining prolonged remission; four of five patients responded to splenectomy and corticosteroids, but one died of infection postoperatively. Five patients, including two treated exclusively with antiplatelet aggregating agents, died without achieving remission. The frequency of successful therapy is not changed by the concurrent pregnancy, but the fetal loss is high. There does seem to be an increased risk of recurrence of TTP in a subsequent pregnancy, and this might be considered when counseling premenopausal patients who have achieved remission of TTP.

Original languageEnglish (US)
Pages (from-to)71-85
Number of pages15
JournalJournal of Clinical Apheresis
Volume1
Issue number2
DOIs
StatePublished - 1983

Fingerprint

Thrombotic Thrombocytopenic Purpura
Plasma Exchange
Pregnancy
Postpartum Period
Platelet Aggregation Inhibitors
Splenectomy
Oral Contraceptives
Counseling
Pregnant Women
Adrenal Cortex Hormones
Therapeutics
Recurrence
Infection

Keywords

  • blood type
  • oral contraceptives
  • plasma exchange
  • preeclampsia
  • pregnancy
  • thrombotic thrombocytopenic purpura

ASJC Scopus subject areas

  • Hematology

Cite this

Thrombotic thrombocytopenic purpura : Report of fourteen cases—occurrence during pregnancy and response to plasma exchange. / Caggiano, Vincent; Fernando, Leonor P; Schneider, Jack M.; Haesslein, Hanns C.; Watson‐Williams, Edward J.

In: Journal of Clinical Apheresis, Vol. 1, No. 2, 1983, p. 71-85.

Research output: Contribution to journalArticle

Caggiano, Vincent ; Fernando, Leonor P ; Schneider, Jack M. ; Haesslein, Hanns C. ; Watson‐Williams, Edward J. / Thrombotic thrombocytopenic purpura : Report of fourteen cases—occurrence during pregnancy and response to plasma exchange. In: Journal of Clinical Apheresis. 1983 ; Vol. 1, No. 2. pp. 71-85.
@article{ad49734ca265454fa0da1ada8999ef79,
title = "Thrombotic thrombocytopenic purpura: Report of fourteen cases—occurrence during pregnancy and response to plasma exchange",
abstract = "Thrombotic thrombocytopenic purpura (TTP), a syndrome of diverse etiology probably related to factors regulating platelet‐vessel wall interaction, is predominantly a disorder of women. We report our experience with 14 patients in an 11‐year period. Thirteen were female and aged between 25–69 years. Four were postmenopausal, and of the nine premenopausal women three were pregnant, one was immediately postpartum, and three were taking estrogennine premenopausal women three were pregnant, one was immediately postpartum, and three were taking estrogen‐containing oral contraceptives. A review of the literature confirms the two to one female/male preponderance and that TTP is reported in 56 women who are pregnant or recently postpartum. While this association with possible hormonal events has been noted, it has previously received little comment. We stress the similarity between TTP and some occurrences of preeclamptic toxemia, and that this may suggest not only a common etiology but that therapeutic attempts should be similar. While no single therapeutic modality is universally successful, our experience is that plasma exchange is the most effective, with five of seven patients so‐treated obtaining prolonged remission; four of five patients responded to splenectomy and corticosteroids, but one died of infection postoperatively. Five patients, including two treated exclusively with antiplatelet aggregating agents, died without achieving remission. The frequency of successful therapy is not changed by the concurrent pregnancy, but the fetal loss is high. There does seem to be an increased risk of recurrence of TTP in a subsequent pregnancy, and this might be considered when counseling premenopausal patients who have achieved remission of TTP.",
keywords = "blood type, oral contraceptives, plasma exchange, preeclampsia, pregnancy, thrombotic thrombocytopenic purpura",
author = "Vincent Caggiano and Fernando, {Leonor P} and Schneider, {Jack M.} and Haesslein, {Hanns C.} and Watson‐Williams, {Edward J.}",
year = "1983",
doi = "10.1002/jca.2920010204",
language = "English (US)",
volume = "1",
pages = "71--85",
journal = "Journal of Clinical Apheresis",
issn = "0733-2459",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Thrombotic thrombocytopenic purpura

T2 - Report of fourteen cases—occurrence during pregnancy and response to plasma exchange

AU - Caggiano, Vincent

AU - Fernando, Leonor P

AU - Schneider, Jack M.

AU - Haesslein, Hanns C.

AU - Watson‐Williams, Edward J.

PY - 1983

Y1 - 1983

N2 - Thrombotic thrombocytopenic purpura (TTP), a syndrome of diverse etiology probably related to factors regulating platelet‐vessel wall interaction, is predominantly a disorder of women. We report our experience with 14 patients in an 11‐year period. Thirteen were female and aged between 25–69 years. Four were postmenopausal, and of the nine premenopausal women three were pregnant, one was immediately postpartum, and three were taking estrogennine premenopausal women three were pregnant, one was immediately postpartum, and three were taking estrogen‐containing oral contraceptives. A review of the literature confirms the two to one female/male preponderance and that TTP is reported in 56 women who are pregnant or recently postpartum. While this association with possible hormonal events has been noted, it has previously received little comment. We stress the similarity between TTP and some occurrences of preeclamptic toxemia, and that this may suggest not only a common etiology but that therapeutic attempts should be similar. While no single therapeutic modality is universally successful, our experience is that plasma exchange is the most effective, with five of seven patients so‐treated obtaining prolonged remission; four of five patients responded to splenectomy and corticosteroids, but one died of infection postoperatively. Five patients, including two treated exclusively with antiplatelet aggregating agents, died without achieving remission. The frequency of successful therapy is not changed by the concurrent pregnancy, but the fetal loss is high. There does seem to be an increased risk of recurrence of TTP in a subsequent pregnancy, and this might be considered when counseling premenopausal patients who have achieved remission of TTP.

AB - Thrombotic thrombocytopenic purpura (TTP), a syndrome of diverse etiology probably related to factors regulating platelet‐vessel wall interaction, is predominantly a disorder of women. We report our experience with 14 patients in an 11‐year period. Thirteen were female and aged between 25–69 years. Four were postmenopausal, and of the nine premenopausal women three were pregnant, one was immediately postpartum, and three were taking estrogennine premenopausal women three were pregnant, one was immediately postpartum, and three were taking estrogen‐containing oral contraceptives. A review of the literature confirms the two to one female/male preponderance and that TTP is reported in 56 women who are pregnant or recently postpartum. While this association with possible hormonal events has been noted, it has previously received little comment. We stress the similarity between TTP and some occurrences of preeclamptic toxemia, and that this may suggest not only a common etiology but that therapeutic attempts should be similar. While no single therapeutic modality is universally successful, our experience is that plasma exchange is the most effective, with five of seven patients so‐treated obtaining prolonged remission; four of five patients responded to splenectomy and corticosteroids, but one died of infection postoperatively. Five patients, including two treated exclusively with antiplatelet aggregating agents, died without achieving remission. The frequency of successful therapy is not changed by the concurrent pregnancy, but the fetal loss is high. There does seem to be an increased risk of recurrence of TTP in a subsequent pregnancy, and this might be considered when counseling premenopausal patients who have achieved remission of TTP.

KW - blood type

KW - oral contraceptives

KW - plasma exchange

KW - preeclampsia

KW - pregnancy

KW - thrombotic thrombocytopenic purpura

UR - http://www.scopus.com/inward/record.url?scp=0020963633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020963633&partnerID=8YFLogxK

U2 - 10.1002/jca.2920010204

DO - 10.1002/jca.2920010204

M3 - Article

VL - 1

SP - 71

EP - 85

JO - Journal of Clinical Apheresis

JF - Journal of Clinical Apheresis

SN - 0733-2459

IS - 2

ER -